|
|
|
|
Explore how NK cells and TILs offer new hope for cancer treatment, potentially overcoming the scalability and safety challenges of current CAR-T cell therapies. Learn about the distinct advantages and manufacturing hurdles of these next-generation immunotherapies.
|
|
|
|
|
Industry 5.0 represents the next evolution in bioproduction—the Adaptive Plant—where human expertise is empowered by AI-driven insights, autonomous systems, and cross-functional collaboration to enhance agility and innovation.
|
|
|
|
|
Multispecific antibodies are redefining cancer therapeutics by tackling tumor complexity through simultaneous target engagement. Learn about the structural design, manufacturing hurdles, regulatory considerations, and integrated solutions accelerating their development.
|
|
|
|
|
Discover how a strategic media supplier delivers a premier experience through streamlined ordering, proactive supply planning, and tailored formulations that keep your programs on track and accelerate time to market.
|
|
|
